Annual Results Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 11.24% vs 6.85% in Mar 2025
Standalone Net Profit
YoY Growth in year ended Mar 2026 is 8.36% vs 23.40% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 8.29% vs 21.95% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 2.22% vs 66.67% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has fallen from Mar 2025
Compare Annual Results Of Jenburkt Pharma With
Figures in Cr
Standalone Annual Results
Change(INR)
Change(%)
Net Sales
168.74
333.37
-164.63
-49.38%
Other Operating Income
0.00
0.00
0.00
Total Operating income
168.74
333.37
-164.63
-49.38%
Raw Material Cost
8.99
164.43
-155.44
-94.53%
Purchase of Finished goods
28.18
0.00
28.18
(Increase) / Decrease In Stocks
-4.85
4.69
-9.54
-203.41%
Employee Cost
49.88
45.78
4.10
8.96%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.01
55.55
-55.54
-99.98%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
42.79
18.68
24.11
129.07%
Total Expenditure (Excl Depreciation)
125.00
289.13
-164.13
-56.77%
Operating Profit (PBDIT) excl Other Income
43.74
44.24
-0.50
-1.13%
Other Income
10.30
3.95
6.35
160.76%
Operating Profit (PBDIT)
54.04
48.19
5.85
12.14%
Interest
0.46
7.88
-7.42
-94.16%
Exceptional Items
-3.95
0.00
-3.95
Gross Profit (PBDT)
49.63
40.31
9.32
23.12%
Depreciation
3.11
10.26
-7.15
-69.69%
Profit Before Tax
46.52
30.04
16.48
54.86%
Tax
11.78
8.67
3.11
35.87%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
34.74
21.37
13.37
62.56%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
34.74
21.37
13.37
62.56%
Equity Capital
4.41
3.02
1.39
46.03%
Face Value
10.00
10.00
0.00
Reserves
192.63
194.15
-1.52
-0.78%
Earnings per share (EPS)
78.78
70.76
8.02
11.33%
Diluted Earnings per share
78.71
70.69
8.02
11.35%
Operating Profit Margin (Excl OI)
25.92%
13.27%
0.00
12.65%
Gross Profit Margin
29.41%
12.09%
0.00
17.32%
PAT Margin
20.59%
6.41%
0.00
14.18%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 168.74 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 11.24% vs 6.85% in Mar 2025
Annual - Standalone Net Profit
Standalone Net Profit 34.74 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 8.36% vs 23.40% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 43.74 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 8.29% vs 21.95% in Mar 2025
Annual - Interest
Interest 0.46 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 2.22% vs 66.67% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 25.92%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has fallen from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
